Last reviewed · How we verify
Amphora
At a glance
| Generic name | Amphora |
|---|---|
| Sponsor | Evofem Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel (PHASE3)
- AMP002 Phase III Contraceptive Study (PHASE3)
- Phase 2B/3 Double-blinded Placebo-controlled (PHASE2, PHASE3)
- Cystoscopic Ablation Via RF Energy Clinical Trial (PHASE1, PHASE2)
- Safety of Acidform Lubricant in HIV-Uninfected Women (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amphora CI brief — competitive landscape report
- Amphora updates RSS · CI watch RSS
- Evofem Inc. portfolio CI